Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog

Test Name: Sunquest Test Code Epic Procedure Code Or ID CPT Code:  


Sunquest Test Code:
EBVCAM      Geisinger Epic Procedure Code: 86665.01         Geisinger Epic ID: 14932

Specimen type:
Preferred collection container:
Alternate Collection Container:
6 mL red-top (plain, non-serum separator) tube
Specimen required:
0.5 mL serum; minimum 0.2 mL

Specimen processing instructions:
Allow to clot. Centrifuge and submit 0.5 mL serum. 
Transport temperature:
Refrigerated (preferred). Room temperature (stable 8 hours) or frozen specimen also acceptable.
Specimen stability:
Room temperature: 8 hours. 2-8°C: 96 hours. Frozen: 6 months.
Rejection criteria:
Stability exceeded or gross hemolysis.

Interpretation guide:
Unit value
< 36.0 u/mL Negative Absence of detectable VCA IgM antibodies. If exposure to Epstein-Barr virus is suspected despite a negative finding, a second sample should be collected and tested no less than one to two weeks later.
36.0 to 43.9 U/mL Equivocal Suggest a second sample be collected and tested one to two weeks later.
> 44.0 U/mL Positive Presence of detectable VCA IgM antibodies. Specific IgM antibodies are usually detected in patients with recent primary infection and may be found in patients with reactivated infections. Other EBV serology assays should be performed to confirm EBV-associated infectious mononucleosis.
CPT code(s):
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
Test includes:
Antibody detection to EBVCA IgM.
Epstein Barr IgM Antibody
Epstein Barr Virus IgM Antibodies to Viral Capsid
Clinical significance:
Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and has also been implicated in Burkitt's lymphoma and nasopharyngeal carcinoma. EBV-VCA IgM antibodies typically appear within 4-6 weeks of infection with IM, peak concurrently with clinical onset of the disease, and decline within 2-3 months. A positive EBV-VCA IgM antibody in conjunction with clinical findings is indicative of an active or recent infection.
Doctoral Director(s:)
Stacy Kenyon, PhD, DABCC
Hoi-Ying Elsie Yu, PhD, DABCC    
Review Date: 10/24/2018

Performing Locations

Geisinger Medical Center

Performing laboratory: Immunology
Technical Lead: Kathy Hurst
Frequency: Sunday, Tuesday through Friday: 1st shift
Performed stat? No
Locations  |    Search  |    Site Map |   Contact Us
©2000-2019 Geisinger Health System.   All rights reserved.
*GMC - Geisinger Medical Center; GWV - Geisinger Wyoming Valley Medical Center; GSACH - Geisinger Shamokin Area Community Hospital; GBH - Geisinger Bloomsburg Hospital;
GCMC - Geisinger Community Medical Center (Scranton); GLH - Geisinger Lewistown Hospital; GHS - Geisinger Holy Spirit; GJSH - Geisinger Jersey Shore Hospital,
GSWB - Geisinger South Wilkes-Barre